Krystal Biotech, Inc. KRYS
NASDAQ · United States · Health Technology
$330.27-2.29 (-0.69%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-03 | 1.79 | 1.70 | +5.2% | $119.22M | -1.4% | -4.8%$341.12→$324.77 |
| Q1 2026 | 2026-05-04 | 1.83 | 1.42 | +28.9% | — | — | +7.0%$266.04→$284.57 |
| Q4 2025 | 2026-02-17 | 1.70 | 1.61 | +5.6% | — | — | +2.5%$276.45→$283.29 |
| Q3 2025 | 2025-11-03 | 2.66 | 1.12 | +137.5% | — | — | +2.9%$197.51→$203.26 |
| Q2 2025 | 2025-08-04 | 1.29 | 1.44 | -10.4% | — | — | — |
| Q4 2024 | 2025-02-19 | 1.53 | 1.85 | -17.3% | — | — | — |
| Q3 2024 | 2024-11-04 | 1.29 | 1.33 | -3.0% | — | — | — |
| Q2 2024 | 2024-08-05 | 0.93 | 0.99 | -6.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.